IntRoductIon
A combination of anticoagulation and epidural catheter has always been a problematic issue. [1] The times of insertion and removal of epidural catheters are high-risk periods for epidural hematoma formation which is a rare but recognized complication. [2] The incidence of epidural hematoma in the setting of epidural catheter placement or removal is reported to be as low as one in 1,50,000. [3] We report a case of paraplegia that developed after removal of a thoracic epidural catheter followed by low molecular weight heparin (LMWH) treatment. Surgical evacuation of epidural hematoma was done following which the patient's symptoms improved gradually and the patient recovered completely.
case RepoRt
A 46-year-old woman (height -160 cm, weight -60 kg) underwent cytoreductive surgery for carcinoma of the left ovary under combined epidural and general anesthesia. Her past medical history was unremarkable, and her preoperative investigations including coagulation profile were within normal limits. Before induction of general anesthesia, an epidural catheter was inserted uneventfully at T7-T8 intervertebral level using 16G Tuohy needle. Epidural space was identified using loss of resistance to saline, with no blood seen through epidural needle and the catheter. Postoperative analgesia was provided with continuous epidural infusion of 0.2% ropivacaine along with 2 mcg/ml of fentanyl at the rate of 5 ml/h. Pneumatic calf pump was started preoperatively and continued in the postoperative period to prevent thromboembolism. On the 3 rd postoperative day, epidural catheter was removed after confirming normal coagulation parameters. For deep vein thromboprophylaxis, a single dose of fractionated heparin (dalteparin 2500 U) was given subcutaneously 6 h after the removal of epidural catheter according to the American Society of Regional Anesthesia and Pain Medicine (ASRA) guidelines.
Six hours after the first dose of dalteparin, the patient complained of severe back pain along with loss of sensory and motor power in the lower limbs. Clinical examination revealed no sensations and muscle power of grade 0/5 in both the lower limbs.
With high index of suspicion of spinal/epidural hematoma causing spinal cord compression, the patient was started on intravenous methylprednisolone infusion, and further dosage of dalteparin sodium was withheld.
Coagulopathy either from the use of anticoagulant, antiplatelet, or thrombolytic medications or from underlying medical conditions is considered one of the major risk factors for epidural hematoma formation related to epidural catheter placement or removal. The American Society of Regional Anesthesia and Pain Medicine (ASRA) has laid down guidelines regarding timing of neuraxial blockade or removal of neuraxial catheters in patients receiving either antithrombotic or thrombolytic therapy. We present a case of acute onset of paraplegia because of an epidural hematoma following removal of the epidural catheter in a patient who was given the first dose of antithrombotic therapy after the removal of the epidural catheter as per the ASRA guidelines. The epidural hematoma was diagnosed with an urgent magnetic resonance imaging, and the patient was urgently taken up for surgical evacuation of the hematoma. The patient made full recovery over 1 week period. Within 2 h of onset of symptoms, an urgent magnetic resonance imaging (MRI) was obtained which revealed a localized epidural hematoma posteriorly from D6 to D8 level causing compression and significant anterior displacement of adjacent spinal cord [ Figure 1 ].
Keywords
The patient was moved to the operating room directly from MRI suite for emergency laminectomy and decompression under general anesthesia. The hematoma was meticulously evacuated, and no active bleeding vessel could be identified [ Figure 2a and b].
She regained some sensory power in the lower limbs on the day of the spine surgery. On the 2 nd postoperative day, some toe movement was seen. There was a gradual improvement in muscle power over the next few days, and on the 7 th postoperative day, the patient had regained normal muscle power of both the lower limbs. Recovery was faster in the left lower limb as compared to right side.
Subsequent follow-up did not reveal any sensory-motor abnormality.
dIscussIon
There has been increased awareness over the last decade about thromboembolic events and has resulted in the administration of prophylactic anticoagulants as a standard of care, to those patients who are at high risk. Epidural anesthesia or analgesia is commonly used in patients undergoing major laparotomies as an adjuvant to general anesthesia and for postoperative pain relief. The time of insertion or removal of the epidural catheter is the high-risk period for the formation of epidural hematoma in patients receiving prophylactic anticoagulation therapy.
In a patient who is already on anticoagulation therapy, the hepatic, renal impairment may affect the onset and duration of action of the anticoagulant. The following abnormal coagulation parameters during the perioperative period have been identified as risk factors for epidural hematoma occurrence. [4] 1. Activated partial thromboplastin time >35 s 2. International normalized ratio >1.5 3. Platelet count <100,000.
This patient neither fits into any of these criteria nor was on any anticoagulant therapy. The first dose of anticoagulant dalteparin was given 6 h after removal of the catheter, well beyond the minimum 2 h interval recommended in the 2010 ASRA guidelines. [5] The latest 2018 guidelines now recommend 4 h interval for the first dose of anticoagulant after epidural catheter removal. If the patient is already receiving prophylactic LMWH, then the guidelines recommend removal of epidural catheter after at least 12 h of administration of the last dose of LMWH. [6] The ASRA guidelines are essentially the consensus statements that represent collective experience of recognized experts in the field of neuraxial anesthesia and anticoagulation. [7] The rarity of this complication and the absence of any mandatory data registry make it extremely difficult to formulate guidelines for exact time interval. In view of our experience, it may be advisable to extend the guideline interval keeping in mind the risk-benefit ratio of doing so and to continue close neurological monitoring of the patient.
For spine imaging, an MRI gives far superior quality of images as compared to computed tomography. However, there is always a worry about subjecting the patient with skin staples and internal vascular clips to an MRI for fear of disrupting the staples and internal clips. Most of the previous case reports have mentioned not subjecting the patient to an MRI for the same reason. However, there is some literature available which supports safety aspect of MRI in patients with staples. In an interesting study on pig feet, it was found that it was safe to use MRI in the presence of skin staples as it did not cause displacement or heating of the skin staples. [8] Another study has also demonstrated safety of MRI of 3 Tesla or less power in the presence of skin staples and vascular occlusion clips. [9] It is vital to confirm the exact diagnosis of a hematoma and its extent before subjecting the patient for an emergency spine surgery.
In some case reports, patients have been managed conservatively. In our case, in spite of early diagnosis and surgical intervention, it took 1 week for complete neurological recovery. The best results have been seen when patients are operated within 12 h of onset of the symptoms. [10] Considering this, conservative management is questionable, and the results are unpredictable.
It may be advisable to extend the ASRA guideline interval for anticoagulant dose after removal of the epidural catheter and to continue close neurological monitoring of the patient. The presence of skin staples or vascular clips should not be a deterrent for subjecting the patient to an MRI for accurate diagnosis. Early diagnosis and surgical intervention offer the best possible chance of neurological recovery.
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